Finance

Lists
301331:SHE
Enwei Pharmaceutical Co Ltd
22,12 CN¥
-0,36%
(-0,080) 1D
9 қаз., 15:04:25 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301331...
Open
22,03 CN¥
High
22,32 CN¥
Low
21,35 CN¥
Mkt. cap
2,28 млрд
Avg. vol.
1,39 млн
Volume
1,32 млн
Dividend
4,66%
Quarterly dividend
0,26 CN¥
Ex-dividend date
2026 ж. 28 мам.
P/E ratio
80,59
52-wk high
33,50 CN¥
52-wk low
18,87 CN¥
EPS
0,27 CN¥
Shares outstanding
102,89 млн
No. of employees
2 мың
Open
22,03 CN¥
High
22,32 CN¥
Low
21,35 CN¥
Mkt. cap
2,28 млрд
Avg. vol.
1,39 млн
Volume
1,32 млн
Dividend
4,66%
Quarterly dividend
0,26 CN¥
Ex-dividend date
2026 ж. 28 мам.
P/E ratio
80,59
52-wk high
33,50 CN¥
52-wk low
18,87 CN¥
EPS
0,27 CN¥
Shares outstanding
102,89 млн
No. of employees
2 мың
News stories
From web sources and news partners
About Enwei Pharmaceutical Co Ltd
CEO-
Employees1,5 мың
Founded1986
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
187,63 млн
263,92 млн
175,33 млн
199,25 млн
Cost of goods sold
102,65 млн
123,62 млн
77,69 млн
105,31 млн
Cost of revenue
102,65 млн
123,62 млн
77,69 млн
105,31 млн
Research and development expenses
1,76 млн
1,22 млн
1,11 млн
1,26 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
91,00 млн
108,50 млн
82,73 млн
90,38 млн
Operating expense
93,18 млн
115,42 млн
85,17 млн
93,84 млн
Total operating expenses
195,83 млн
239,04 млн
162,86 млн
199,15 млн
Operating income
-8,20 млн
24,87 млн
12,47 млн
102,77 м.
Other non operating income
341,20 м.
-843,50 м.
-62,65 мың
-245,26 м.
EBT including unusual items
-2,54 млн
20,98 млн
13,88 млн
4,07 млн
EBT excluding unusual items
-6,27 млн
25,60 млн
13,52 млн
248,11 м.
Income tax expense
-782,36 м.
5,62 млн
1,38 млн
553,50 м.
Effective tax rate
30,78%
26,77%
9,93%
13,59%
Other operating expenses
2,36 млн
3,57 млн
1,89 млн
2,41 млн
Net income
-1,76 млн
15,36 млн
12,50 млн
3,52 млн
Net profit margin
-0,94%
5,82%
7,13%
1,77%
Earnings per share
-
-
-
-
Interest and investment income
2,19 млн
1,88 млн
1,69 млн
892,61 м.
Interest expense
-606,94 м.
-308,97 м.
-578,12 м.
-502,01 м.
Net interest expenses
1,59 млн
1,57 млн
1,11 млн
390,60 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
3,02 млн
36,41 млн
24,01 млн
12,01 млн
Gain or loss from assets sale
-263,27 м.
138,01 м.
-
-2,69 млн
AI content may include mistakes. Learn more
Google қолданбалары